News

Amaran Biotech will participate in BioJapan 2025 from October 8–10 at Pacifico Yokohama, together with BPIPO(Biotechnology and Pharmaceutical Industries Promotion Office), DCB(Development Center for Biotechnology), and fellow biotech companies from Taiwan. As one of Asia’s most influential biotech and pharma exhibitions, BioJapan brings together exhibitions, seminars, and partnering meetings, serving as a key platform for global collaboration. 📍 You can find us at the Taiwan Pavilion, Booth B-77.🤝 Book a meeting with us by searching “Amaran” on the BioJapan partnering platform, or contact us directly at service@amaranbiotech.com. We look forward to meeting our partners and exploring new opportunities in Yokohama.

In the pharmaceutical sector, the pathway from innovative science to successful commercialization is governed by two inseparable forces: Scientific Progress and Regulatory Integrity. At Amaran Biotech, our Quality Assurance philosophy is proactive and deeply integrated. We employ a Quality by Design (QbD) approach to establish our systems, building quality into our processes from the earliest stages. Our entire framework is meticulously structured to exceed global Good Manufacturing Practice (GMP) requirements, creating a robust and scalable process ready for large-scale production. Furthermore, our commitment extends to rigorous continuous improvement. Through robust data analysis and a disciplined Corrective and Preventive Action (CAPA) […]

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was awarded the “Best Fill-Finish” at the 2025 Asia-Pacific Biologics CDMO Excellence Awards held in Singapore on September 10. This honor recognizes Amaran Biotech’s leading capabilities in aseptic fill-finish processes and marks an important step for Taiwan’s biotech industry on the international stage. The Asia-Pacific Biologics CDMO Excellence Awards, organized by the renowned international consulting firm IMAPAC, celebrate CDMOs in the region that have made outstanding contributions to biologics innovation and manufacturing. This year, Amaran Biotech was nominated for its achievements in supporting international clients with large-molecule drug fill-finish and […]

Purifying natural products is a highly specialized process that demands precision, scientific rigor, and strict quality control. Each stage must be justified not only for technical efficiency but also for regulatory compliance, risk mitigation, reproducibility, and cost-effectiveness. From active pharmaceutical ingredients (APIs) to high-value bioactives, every process step must align with Good Manufacturing Practice (cGMP) standards while maintaining scalability and production efficiency.  Below are Critical Steps in Natural Product Purification,  1. Raw Material Sourcing & Pre-treatment: Carefully selecting a stable, well-characterized source (plant, microorganism, marine organism, etc.) — and confirming species, origin, harvest time, and quality — ensures process stability. Pre-treatment […]

The highly anticipated annual biotechnology event — BIO Asia–Taiwan 2025 Exhibition— will be held from July 24 to 27 at the Taipei Nangang Exhibition Center. Amaran Biotech is proud to debut its new brand identity and vision, showcasing major advancements in aseptic filling line, adjuvant technologies, and global partnerships. Visit us at Booth M726, located in the CDMO zone — we warmly welcome industry partners for dialogue and collaboration. As a one-stop Contract Development and Manufacturing Organization (CDMO), Amaran Biotech provides integrated solutions encompassing vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, and aseptic filling of drug products. With the implementation of a […]

A High-Efficiency Alternative to GC-MS for Commercial-Scale Product Testing GC-MS is commonly used in early-stage development of pharmaceuticals and biotech products due to its high sensitivity and selectivity, particularly for limited, complex samples requiring structural identification. However, as the product moves into commercial-scale production, the high cost and operational complexity of GC-MS become burdensome for routine quality control. Amaran Biotech successfully assisted clients in converting their GC-MS method for residual solvent analysis to a more efficient and stable GC-FID method. Three Key Advantages of GC-FID Implementation:🔹 Enhanced Efficiency: Ideal for situations requiring a large number of repeated analyses, routine quality […]

To help the pharmaceutical industry meet upcoming regulatory requirements, we have successfully completed tooling for pre-filled syringes and are advancing to the next phase of testing preparation and service deployment. With USP <382> set to be implemented in December 1 2025, regulating the functional suitability of elastomeric components (such as plungers) in parenteral packaging and delivery systems. Testing services will be available shortly to support your compliance and quality assurance needs.